Giant vesicles containing superparamagnetic iron oxide as biodegradable cell-tracking MRI probes.

A major breakthrough in in vivo cellular imaging has been the clinical/preclinical use of magnetic resonance imaging (MRI) with contrast agent. Superparamagnetic iron oxide (SPIO) is a promising candidate for the development of smart MRI probes for cell-tracking. In the present study, we describe biodegradable probes made of giant vesicles (GVs; closed lipid membranes with diameters >1 μm) that encapsulate SPIO for use as an MRI contrast agent. These SPIO-containing GVs (SPIO-GVs) exhibited excellent contrast enhancement in the single cell of medaka fish (Oryzias latipes) embryos immediately after their microinjection, and this enhancement disappeared when the GV membranes were destroyed. Our results demonstrate that SPIO-GVs are useful MRI probes for single cell-tracking that have minimum cytotoxicity and will greatly improve clinical/preclinical in vivo cellular imaging techniques.

[1]  M. Morita,et al.  Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent. , 2010, Bioconjugate chemistry.

[2]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[3]  T. Saga,et al.  A medaka model of cancer allowing direct observation of transplanted tumor cells in vivo at a cellular-level resolution , 2009, Proceedings of the National Academy of Sciences.

[4]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[5]  Valérie Cabuil,et al.  Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.

[6]  M. Rausch,et al.  In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO , 2002, NMR in biomedicine.

[7]  Scott E. Fraser,et al.  Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study , 2004, NeuroImage.

[8]  C. Ménager,et al.  Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy. , 2007, Angewandte Chemie.

[9]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[10]  K. Maruyama,et al.  Globin Gene Enhancer Activity of a DNase-I Hypersensitive Site-40 Homolog in Medaka, Oryzias latipes , 2007, Zoological science.

[11]  Pasquale Stano,et al.  Giant Vesicles: Preparations and Applications , 2010, Chembiochem : a European journal of chemical biology.

[12]  C. Ménager,et al.  In situ precipitation of magnetic fluid encapsulated in giant liposomes. , 2010, Journal of colloid and interface science.

[13]  Piotr Walczak,et al.  Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. , 2011, Contrast media & molecular imaging.

[14]  Gabriel P. Krestin,et al.  Clinically Translatable Cell Tracking and Quantification by MRI in Cartilage Repair Using Superparamagnetic Iron Oxides , 2011, PloS one.

[15]  Makoto Furutani-Seiki,et al.  Single cell lineage and regionalization of cell populations during Medaka neurulation , 2004, Development.

[16]  T. Ishida,et al.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Florence Gazeau,et al.  Universal cell labelling with anionic magnetic nanoparticles. , 2008, Biomaterials.

[18]  M. Rausch,et al.  Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage , 2001, Magnetic resonance in medicine.

[19]  A. Bjørnerud,et al.  pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. , 2001, Magnetic resonance imaging.

[20]  B. Nordén,et al.  Controlled drug release under a low frequency magnetic field: effect of the citrate coating on magnetoliposomes stability , 2011 .

[21]  J. Minna,et al.  A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer Imaging. , 2009, Journal of materials chemistry.

[22]  M. Tomita,et al.  Efficient formation of giant liposomes through the gentle hydration of phosphatidylcholine films doped with sugar. , 2009, Colloids and surfaces. B, Biointerfaces.

[23]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[24]  J. Zasadzinski,et al.  Multiple lipid compartments slow vesicle contents release in lipases and serum. , 2007, ACS nano.

[25]  T. Skotland,et al.  In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. , 2002, Journal of pharmaceutical and biomedical analysis.

[26]  Tilcock Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. , 1999, Advanced drug delivery reviews.

[27]  Jeff W M Bulte,et al.  In vivo MRI cell tracking: clinical studies. , 2009, AJR. American journal of roentgenology.

[28]  S. Lesieur,et al.  Evidence of surfactant-induced formation of transient pores in lipid bilayers by using magnetic-fluid-loaded liposomes. , 2003, Journal of the American Chemical Society.

[29]  R. Rowland,et al.  The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. , 1980, Biochimica et biophysica acta.

[30]  Jeff W M Bulte,et al.  In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  C. Ménager,et al.  Reversible Shrinkage of Giant Magnetoliposomes under an Osmotic Stress , 2002 .

[32]  K. Maruyama,et al.  Expression of brain-type fatty acid-binding protein (fabp7) in medaka during development. , 2008, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[33]  Colin D. Bain,et al.  Interfacial films and wetting behavior of hexadecane on aqueous solutions of dodecyltrimethylammonium bromide , 2003 .

[34]  David A. Weitz,et al.  Production of Unilamellar Vesicles Using an Inverted Emulsion , 2003 .

[35]  B. Nordén,et al.  Magnetically Triggered Release From Giant Unilamellar Vesicles: Visualization By Means Of Confocal Microscopy , 2011 .

[36]  Ralph Weissleder,et al.  Long-circulating iron oxides for MR imaging , 1995 .

[37]  Masanori Fujinami,et al.  Population analysis of structural properties of giant liposomes by flow cytometry. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[38]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Mark W Dewhirst,et al.  Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. , 2007, Journal of the National Cancer Institute.

[40]  J. Bulte,et al.  Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. , 2004, Methods in enzymology.

[41]  K. Maruyama,et al.  1kbp 5' upstream sequence enables developmental stage-specific expressions of globin genes in the fish, medaka Oryzias latipes. , 2012, Gene.

[42]  S. Atlas,et al.  Calcified intracranial lesions: detection with gradient-echo-acquisition rapid MR imaging. , 1988, AJR. American journal of roentgenology.

[43]  H. Honda,et al.  MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient‐echo imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[44]  T. Okano,et al.  A polymeric micelle MRI contrast agent with changeable relaxivity. , 2006, Journal of controlled release : official journal of the Controlled Release Society.